Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Cancer Pain Management Using a Web-based Intervention

for
Cancer of Breast, Depressive Symptoms, Cancer Pain
Location: Nashville TN
Sponsor: Vanderbilt University

Sex: Female

Age: 18+

Code: NCT06085313

Recruiting

Long-Term Follow-Up of Recipient of Gene Transfer Research

for
Retroviridae Infections, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT01492036

Recruiting

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 21+

Code: NCT05054413

Recruiting

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

for
Breast Cancer
Location: Bensalem PA, Norfolk VA, Columbia MD, Salem VA,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05748834

Phase 2, Recruiting

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

for
End of Life, Cancer
Location: Birmingham AL, Mobile AL, Salt Lake City UT, Duarte CA,
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT05297734

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Exercise in Metastatic Breast Cancer: EMBody

for
Breast Cancer, Indolent Metastatic Breast Cancer
Location: Boston MA, Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT05468034

Recruiting

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer

for
Breast Carcinoma, Head and Neck Cancer, Lung Cancer
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 21+

Code: NCT05787834

Recruiting

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

for
Impaired Cognition, Chemo-brain, Breast Cancer
Location: Salem MA, Boston MA
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 60+

Code: NCT02290834

Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

for
Large Cell Lymphoma, Diffuse, Relapsed Cancer,
Location: Charlottesville VA, Detroit MI, Indianapolis IN,
Sponsor: Vijendra Singh

Sex: All

Age: 18+

Code: NCT05852717

Phase 2, Recruiting

Evaluating Disparities in Precision Oncology

for
Metastatic Cancer, Advanced Cancer
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT06081517

Recruiting

EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer

for
Cancer
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: All

Age: 20 - 70+

Code: NCT06083324

Recruiting

3D Ultrasound Breast Imaging

for
Breast Tumor
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: Female

Age: 18+

Code: NCT04692818

Recruiting

Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy

for
Early-stage Breast Cancer
Location: Ottawa, Kingston, Oshawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT05753618

Recruiting

Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study

for
Breast Cancer
Location: New York NY, Brooklyn NY
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 19 - 70+

Code: NCT04371913

Recruiting

CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth

for
Cancer
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 18+

Code: NCT05405413

Phase 2, Recruiting

Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

for
Pediatric Cancer
Location: Chicago IL
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

Sex: All

Age: 0+

Code: NCT05120518

Recruiting

Galleri® in the Medicare Population.

for
Cancer
Location: Rockledge PA, Philadelphia PA, Furlong PA,
Sponsor: GRAIL, Inc.

Sex: All

Age: 50+

Code: NCT05673018

Recruiting

A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers

for
Cancer Patients, Care Givers
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 40+

Code: NCT06305741

Recruiting

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

for
Locally Advanced Unresectable or Metastatic Solid Tumors
Location: Irving TX, Austin TX, San Antonio TX
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All

Age: 18+

Code: NCT05458219

Phase 1, Recruiting

SMP-3124LP in Adults With Advanced Solid Tumors

for
Solid Tumor
Location: Celebration FL, Columbus OH, Nashville TN, Denver CO,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT06526819

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial